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Abstract Nucleotides are released not only from neurons,
but also from various other types of cells including
fibroblasts, epithelial, endothelial and glial cells. While
ATP release from non-neural cells is frequently Ca
2+
independent and mostly non-vesicular, neuronal ATP
release is generally believed to occur via exocytosis. To
evaluate whether nucleotide release from neuroendocrine
cells might involve a non-vesicular component, the auto-
crine/paracrine activation of P2Y12 receptors was used as a
biosensor for nucleotide release from PC12 cells. Expres-
sion of a plasmid coding for the botulinum toxin C1 light
chain led to a decrease in syntaxin 1 detected in
immunoblots of PC12 membranes. In parallel, spontaneous
as well as depolarization-evoked release of previously
incorporated [
3H]noradrenaline from transfected cells was
significantly reduced in comparison with the release from
untransfected cells, thus indicating that exocytosis was
impaired. In PC12 cells expressing the botulinum toxin C1
light chain, ADP reduced cyclic AMP synthesis to the same
extent as in non-transfected cells. Likewise, the enhance-
ment of cyclic AMP synthesis either due to the blockade of
P2Y12 receptors or due to the degradation of extracellular
neucleotides by apyrase was not different between non-
transfected and botulinum toxin C1 light chain expressing
cells. However, the inhibition of cyclic AMP synthesis
caused by depolarization-evoked release of endogenous
nucleotides was either abolished or greatly reduced in cells
expressing the botulinum toxin C1 light chain. Together,
these results show that spontaneous nucleotide release from
neuroendocrine cells may occur independently of vesicle
exocytosis, whereas depolarization-evoked nucleotide re-
lease relies predominantly on exocytotic mechanisms.
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Introduction
Adenine and uridine nucleotides are present in and released
from all types of cells [2] and exert effects via P2X and/or
P2Y receptors: P2X receptors are ATP-gated cation
channels [25]; P2Y receptors are G protein-coupled
receptors, and eight different types have been identified
(P2Y1, 2, 4, 6, 11, 12, 13, 14;[ 1]). P2Y1, 11, 12 and 13 are
activated by adenine nucleotides, whereas P2Y6 is activated
by uridine nucleotides. P2Y2 and 4 are sensitive to adenine
and uridine nucleotides, and P2Y14 is activated by UDP-
glucose. In a large number of non-neural tissues, e.g. liver,
kidney, bones and blood vessels, released nucleotides
subserve autocrine/paracrine functions by activating certain
P2Y receptors [32, 16, 38, 12, 30]. In a given cell, this
autocrine/paracrine regulation depends on the release of
nucleotides, the presence of P2Y receptors and occasionally
on the enzymatic activities of nucleotidases: in hepatoma
cells [16], for instance, released ATP is degraded to ADP to
stimulate P2Y1 receptors; in epithelial [32] and osteoblastic
[38] cells, in contrast, ATP itself activates P2Y11 and P2Y2
receptors, respectively.
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e-mail: stefan.boehm@meduniwien.ac.atAlthough ATP has first been described to be released
from neurons [15] and to act as a neurotransmitter [6],
available information about neuronal autoregulation via
released nucleotides and P2Y receptors is limited. Early
examples were the feedback inhibition of sympathetic
transmitter release via presynaptic P2Y receptors (see [4])
and the ATP-mediated autocrine inhibition of voltage-
activated Ca
2+ channels in bovine chromaffin cells [9].
More recently, autoregulation via P2Y receptors has been
described for the phaeochromocytoma cell line PC12 [24].
There, endogenous P2Y12 receptors were activated by
spontaneous nucleotide release to achieve half-maximal
inhibition of cyclic AMP (cAMP) synthesis. Depolarization
of PC12 cells by 100 mM K
+ further enhanced nucleotide
release and thereby led to full inhibition of cAMP
generation. This latter effect was prevented when voltage-
activated Ca
2+ channels were blocked by Cd
2+ or when
extracellular nucleotides were degraded by apyrase. Thus,
the inhibition of cAMP synthesis in PC12 cells via P2Y
receptors can be viewed as a biosensor for nucleotide
release [24].
Nucleotides are released from various cells including
fibroblast-like, epithelial, endothelial, glial and neuronal
cells [36, 28, 21, 26, 35]. ATP release from non-neural cells
can be elicited by different stimuli, such as hypotonic
solutions [36], mechanical stimulation [28] or exchange of
culture media [21, 26] and is frequently Ca
2+ independent
and therefore most probably non-vesicular. The mechanisms
underlying this non-vesicular ATP release remained largely
elusive, but ATP binding cassette transporters, stretch-
activated cation channels as well as connexin hemichannels
have been implicated [22]. In addition, evidence has been
presented that indicates that nucleotide release from non-
neural cells may to some extent be vesicular (e.g. [17, 8]).
In neurons and neuroendocrine cells, ATP is stored in
vesicles either alone or together with classic neurotransmit-
ters and is thus released by exocytosis [27]. Vesicle
exocytosis occurs spontaneously at a slow rate and is
largely accelerated when Ca
2+ entry is triggered by
depolarization-induced opening of voltage-activated Ca
2+
channels [29]. Accordingly, depolarization-evoked ATP
release from neurons and neuroendocrine cells is entirely
Ca
2+ dependent [35, 13], but it remained unknown whether
all of the spontaneous nucleotide release from neuronal
sources is also vesicular.
Vesicle exocytosis in neurons and neuroendocrine cells
involves the SNARE proteins syntaxin, SNAP-25 and
VAMP/synaptobrevin. These proteins are cleaved by
various serotypes of clostridial neurotoxins which thereby
prevent exocytosis. In particular, botulinum neurotoxin C1
cleaves syntaxin, and in some cells also SNAP-25, and
thereby impedes spontaneous as well as Ca
2+-evoked
vesicle exocytosis [5]. Transfection of PC12 cells with a
plasmid coding for the botulinum toxin C1 light chain was
reported to largely reduce spontaneous as well as depolar-
ization-evoked release of co-transfected human growth
hormone [10]. Here, we used an analogous method to
investigate whether in PC12 cells the activation of P2Y12
receptors by endogenously released nucleotides relies on
vesicle exocytosis.
Materials and methods
Materials
[2,8−
3H]adenine (specific activity 32 Ci mmol
−1) and levo-
[ring-2,5,6-
3H]noradrenaline (specific activity 37 Ci
mmol
−1) were obtained from NEN (Vienna, Austria). Na-
ADP, 4-(3-butoxy-4-methoxybenzyl)imidazoline-2-one
(RO 20-1724), 3′,5′-cyclic AMP, apyrase (grade VII, with
an approximately 1:1 ratio in ATPase and ADPase activity),
2-methylthio-AMP, and 2-p-(2-carboxyethyl)phenethylamino-
5′-N-ethylcarboxamido-adenosine (CGS 21680) were pur-
chased from Sigma (Vienna, Austria).
Cell culture and transfection
PC12 cells were maintained and subcultured as previously
described in detail [24]. The cells were plated onto
collagen-coated (Biomedical Technologies Inc., Stoughton,
MA, USA) culture dishes (NUNC, Roskilde, Denmark) and
were kept in OptiMEM (InVitrogen, Vienna, Austria)
supplemented with 0.2 mM L-glutamine (HyClone, Aalst,
Belgium), 25,000 IU l
−1 penicillin and 25 mg l
−1
streptomycin (Sigma, Vienna, Austria), 5% fetal calf serum
and 10% horse serum (both InVitrogen, Vienna, Austria).
Once per week, cell cultures were split; the medium was
exchanged twice per week. To investigate the outflow of
previously incorporated [
3H]noradrenaline under continu-
ous superfusion, PC12 cells were plated onto 5-mm discs,
for assays of cAMP accumulation they were plated onto 6-
well culture dishes and for membrane preparations for
Western blots they were plated onto 100-mm culture dishes.
All this tissue culture plastic was coated with collagen (as
above).
For the generation of PC12 cell clones stably expressing
the botulinum toxin C1 light chain (BoNT/C1), 15 μgo fa
pcDNA3 vector harbouring the botulinum toxin C1 light
chain (pBoNT/C1; kindly provided by R.D. Burgoyne,
Liverpool, UK) [10] were mixed with 50 μlo ft h e
TransFast transfection reagent (Promega, Mannheim, Ger-
many) and added to semiconfluent PC12 cell cultures in
serum-free medium. After a 1 h incubation at 37°C, two
additional volumes of serum-free medium and the appro-
priate amount of serum (as above) were added. This
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medium supplemented with 500 μg/ml neomycin (G418)
to allow for selection of drug resistance. This selection
medium was replaced every 3–4 days until distinct islands
of surviving cells were visible. Individual clones of
antibiotic-resistant cells were transferred to 24-well plates
and grown in medium containing 200 μg/ml G418.
Immunoblotting of SNARE proteins
Preparation of protein extracts of PC12 membranes was
performed as described previously [18]. Materials and
methodology used for production and analysis of ECL-
immunoblots were also essentially as described therein,
with the following modifications: protein extracts in SDS
sample buffer were incubated at 95°C for 5 min and
subjected to sodium dodecyl sulphate polyacrylamide gel
electrophoresis (SDS-PAGE) on 5% (stacking) and 10%
(separating) gels. After electrophoretic transfer of proteins
to nitrocellulose, membranes were cut horizontally along
appropriate molecular weight markers in order to separate
regions harbouring proteins with apparent molecular
weights of 10–20 kD, 21–29 kD and 30–50 kD. These
membrane strips were incubated in one of the following
monoclonal SNARE antibodies: syntaxin 1 antibody clone
78.3, synaptobrevin 2 antibody clone 69.1 (both obtained
from Synaptic Systems, Göttingen, Germany) and SNAP-
25 antibody MAB331 (purchased from Chemicon, Temecula,
CA, USA).
Measurement of [
3H]noradrenaline release
[
3H]noradrenaline uptake in and superfusion of PC12 cell
cultures were performed as described previously [23].
Culture discs with PC12 cells were incubated in 0.1 μM
[
3H]noradrenaline in culture medium supplemented with
1 mM ascorbic acid at 36°C for 1 h. After labelling, culture
discs were transferred to small chambers and superfused
with a buffer containing (mM) NaCl (120), KCl (3.0), CaCl2
(2.0), MgCl2 (2.0), glucose (20), hydroxyethylpiperazine
ethanesulphonic acid (HEPES) (10), fumaric acid (0.5), Na-
pyruvate (5.0), ascorbic acid (0.57) and desipramine (0.001),
adjusted to pH 7.4 with NaOH. Superfusion was performed
at 25°C at a rate of about 1.0 ml/min. Collection of 4-min
superfusate fractions was started after a 60-min washout
period to remove excess radioactivity.
Depolarization-dependent overflow of previously incor-
porated [
3H]noradrenaline was triggered by inclusion of 30
or 100 mM KCl in the superfusion buffer during two 30-s
periods 20 min apart (Fig. 2a). At the end of the experi-
ments, the radioactivity remaining in the cells was extracted
by immersion of the discs in 2% (v/v) perchloric acid
followed by sonication. Radioactivity in extracts and
collected fractions was determined by liquid scintillation
counting (Packard Tri-Carb 2100 TR).
The spontaneous (unstimulated) rate of [
3H] outflow was
obtained by expressing the radioactivity of a collected
fraction as percentage of the total radioactivity in the
cultures at the beginning of the corresponding collection
period. Values obtained during the 4-min period directly
preceding the application of 30 mM K
+ were used for the
comparison of spontaneous (basal) tritium outflow in wild-
type and pBoNT/C1 expressing PC12 cells. K
+-evoked
tritium overflow was calculated as the difference between
the total [
3H] outflow during and after stimulation and the
estimated basal outflow which was assumed to decline
linearly throughout the experiments. Therefore, basal
outflow during periods of stimulation was assumed to
equate the arithmetic mean of the samples preceding and
those following stimulation, respectively. The difference
between the total and the estimated basal outflow was
expressed as a percentage of the total radioactivity in the
cultures at the beginning of the respective stimulation (% of
total activity).
Determination of cyclic AMP
The accumulation of cAMP in PC12 cell cultures was
determined as described before [33]. After labelling of
cellular purines with tritiated adenine (2.5 μCi/ml for 12 h),
the medium was replaced by a buffer (120 mM NaCl,
3 mM KCl, 2 mM MgCl2, 2 mM CaCl2, 20 mM glucose,
10 mM HEPES, 10 mM LiCl, adjusted to pH 7.4 with
NaOH) supplemented with 100 μM of the phosphodiesterase
inhibitor Ro-20-1724 [4-(3-butoxy-4-methoxybenzyl)
imidazolidin-2-one] and 1 U/ml adenosine deaminase.
Dishes were then kept at room temperature for 105 min.
During the last 15 min of this incubation period, the
adenosine A2A receptor agonist 2-p-(2-carboxyethyl)
phenethylamino-5′-N-ethylcarboxamido-adenosine (CGS
21680), ADP (10 μM), apyrase (1 U/ml) or 100 mM KCl
(NaCl was reduced accordingly) were also included in the
medium. When appropriate, the P2Y12 receptor antagonist
2MesAMP (100 μM; [14]) was present for the last 25 min.
The incubation was terminated by exchanging the buffer for
1 ml of 2.5% perchloric acid containing 100 μM non-
labelled cAMP followed by a 20-min incubation at 4°C.
Subsequently, cAMP was separated from the other purines
by a chromatographic procedure described before [33]. One
tenth of each sample obtained as described above was used
for the determination of the total radioactivity. The
remaining 900 μl were neutralised by addition of 100 μl
4.2 M KOH and applied to Dowex 50 columns (AG 50W-
X4; Bio-Rad, Vienna, Austria), which were then rinsed
with 3 ml H2O. The eluate obtained by the subsequent
application of 8 ml H2O was directly poured onto alumina
Purinergic Signalling (2007) 3:367–375 369columns (Bio-Rad, Vienna, Austria), which were then
washed with 6 ml H2O. Finally, cAMP was eluted with
4 ml imidazole buffer (20 mM imidazole in 0.2 M NaCl;
pH 7.45). Radioactivity within the samples obtained was
determined by liquid scintillation counting. The radioactiv-
ity in the fraction of cAMP was expressed as percentage of
the total radioactivity incorporated in the cells.
Stimulation of PC12 cells, whether they were clonal cell
lines or wild-type cells, with the adenosine A2A receptor
agonist CGS 21680 caused reproducible increases in the
values of cAMP. However, the extent of basal and
stimulated cAMP synthesis may vary between different
preparations [33]. Hence, to be able to directly compare
changes in CGS 21680-induced cAMP synthesis in
different cell clones, values obtained in the presence of
ADP, apyrase, 2MesAMP or KCl were expressed as
percentage of the values obtained in the very same
preparation, but in the absence of these agents (% of
control).
Statistics
All data represent arithmetic means±SEM; n represents
numbers of culture dishes. Statistical significance of differ-
ences between single data points was evaluated by the non-
parametric Mann-Whitney test, and p values<0.05 were
accepted as indicators of significance.
Results
To assess the role of vesicle exocytosis in the release of
endogenous nucleotides from neuroendocrine cells, this
study employed the autocrine/paracrine control of cAMP
synthesis in PC12 cells via P2Y12 receptors. To prevent
vesicle exocytosis, we generated cell clones stably express-
ing pBoNT/C1. Depending on the cell types being
investigated, this toxin cleaves one or more SNARE
proteins and thereby prevents vesicular transmitter release
or hormone secretion [5].
Cleavage of SNARE proteins by the expression
of the BoNT/C1 light chain
The major target of BoNT/C1 is syntaxin 1, which is
cleaved by this toxin in all types of preparations [5].
Therefore, several pBoNT/C1 expressing clones were
initially tested in immunoblots of harvested membranes
for a lack of full-length syntaxin. Two of these pBoNT/C1
expressing clones (BT2 and BT7) were selected for further
analysis.
In bovine chromaffin cells, BoNT/C1 was reported to
cleave not only syntaxin 1, but also SNAP-25, even though
the toxin failed to cleave purified and recombinant SNAP-
25 [11]. To evaluate the efficiency of SNARE protein
cleavage by the BoNT/C1 light chain expressed in PC12
cells, the immunostaining of syntaxin and SNAP-25 in
Western blots was compared with that of synaptobrevin,
which is undoubtedly insensitive to BoNT/C1 [11, 5]. As
shown in Fig. 1, the stable expression of pBoNT/C1
markedly reduced or even abolished the staining of a
protein with an apparent molecular weight of 37 kD by an
anti-syntaxin antibody. In contrast, there were no clear-cut
reductions in the staining of a 25-kD band by an anti-
SNAP-25 antibody, and occasionally the immunostaining
of this protein appeared to be even enhanced in pBoNT/C1
expressing clones (Fig. 1a). To quantify these changes in
SNARE protein expression, the immunoblots were quanti-
fied by densitometry and the values obtained for the anti-
syntaxin and anti-SNAP-25 immunoreactive bands were set
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Fig. 1 Identification of SNARE proteins in membrane extracts from
either wild-type (WT, untransfected) PC12 cells or from two PC12 cell
clones stably expressing pBoNT/C1 (BT2 and BT7). SDS-membrane
extracts were separated on SDS-PAGE and transferred to nitrocellulose
membranes. The membranes were cut horizontally to separate regions
harbouring proteins with apparent molecular weights of 1–20 kD, 21–
29 kD and 30–50 kD and immunostained with anti-syntaxin 1
antibody clone 78.3 (Stx), anti-SNAP-25 antibody MAB331 (S25)
and anti-synaptobrevin 2 antibody clone 69.1 (Sb), respectively.
a Representative blot obtained as described above. b The relation
between the anti-syntaxin and the anti-synaptobrevin immunoreac-
tivities (Stx/Sb) as determined by densitometric analysis (n=3). c The
relation between the anti-SNAP-25 and the anti-synaptobrevin immu-
noreactivities (Stx/Sb) as determined by densitometric analysis (n=3).
*Significant differences versus the results obtained with membranes
from wild-type cells at p<0.05
370 Purinergic Signalling (2007) 3:367–375in relation to those of the anti-synaptobrevin immunoreac-
tive bands (Fig. 1b). This procedure revealed a significant
reduction of syntaxin in the pBoNT/C1 expressing clones
when compared with wild-type PC12 cells. SNAP-25
immunoreactivity, in contrast, was not significantly altered
in these cell clones.
Inhibition of transmitter release by the expression
of the BoNT/C1 light chain
Previously, it has been shown that the transient expression
of pBoNT/C1 reduced stimulated vesicular catecholamine
release from PC12 cells [10]. To evaluate whether
catecholamine release was reduced in the pBoNT/C1
expressing clones, clonal and wild-type PC12 cells were
labelled with [
3H]noradrenaline and the basal and depolar-
ization-dependent outflow of radioactivity was determined.
After washout of excess radioactivity during a 1-h washout
period, all PC12 cell cultures steadily released small
amounts of radioactivity in the superfusion buffer
(Fig. 2a). However, this spontaneous outflow of radioac-
tivity was significantly less in the two pBoNT/C1 express-
ing clones than in untransfected PC12 cells (Fig. 2b).
In wild-type cells, the presence of 30 mM K
+ (Na
+ was
reduced accordingly) for 30 s caused a reproducible
increase in the outflow of radioactivity (Fig. 2a), but such
an effect was hardly observed in the pBoNT/C1 expressing
clones. Accordingly, the overflow of radioactivity triggered
by 30 mM K
+ was significantly reduced in the pBoNT/C1
expressing clones in comparison with wild-type cells
(Fig. 2c). This confirms that the expression of the BoNT/
C1 light chain reduced spontaneous noradrenaline release
and almost abolished release due to mild depolarizations.
Large intracellular Ca
2+ increases have been reported to
rescue transmitter release from cells poisoned with BoNT/
C1 [7]. Therefore, PC12 cultures were also exposed to
100 mM K
+ (Na
+ was again reduced) for 30 s. Although
this stimulation paradigm caused unequivocal increases in
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Fig. 2 Basal and depolarization-evoked [
3H]noradrenaline release
from either wild-type (WT, untransfected) PC12 cells or from two
PC12 cell clones stably expressing pBoNT/C1 (BT2 and BT7). PC12
cell cultures were labelled with [
3H]noradrenaline and superfused.
Subsequent to a 60-min washout period, 4-min fractions of superfusate
were collected. Tritium overflow was stimulated twice (S1 after
72 min and S2 after 92 min of superfusion) by the presence of KCl
(30 or 100 mM, each for 30 s). a Comparison of the time courses of
fractional [
3H] outflow from the three different kinds of cell cultures
(n=5 to 6). b The amount of basal [
3H] outflow from the three PC12
cell cultures (n=8 to 9). c The amount of [
3H] overflow from the three
PC12 cell cultures triggered by 30 mM KCl (n=8 to 9). d The amount
of [
3H] overflow from the three PC12 cell cultures triggered by
100 mM KCl (n=8 to 9). *, **, ***Significant differences versus the
results obtained with wild-type cells at p<0.05, p<0.01 and p<0.001,
respectively
Purinergic Signalling (2007) 3:367–375 371the outflow of radioactivity even from pBoNT/C1 express-
ing cells (Fig. 2a), the amount of tritium overflow was still
reduced when compared with the values obtained in
untransfected PC12 cells (Fig. 2d). Thus, the expression of
the BoNT/C1 light chain efficiently reduced spontaneous as
well as depolarization-evoked vesicular transmitter release.
Changes in the regulation of cAMP synthesis via P2Y
receptors due to the expression of the BoNT/C1 light chain
In PC12 cells, activation of endogenous P2Y12 receptors by
the exposure to nucleotides causes an inhibition of adenylyl
cyclase [33]. Furthermore, spontaneously released nucleo-
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Fig. 3 Changes in cAMP synthesis caused by exogenous ADP or
endogenously released nucleotides in either wild-type (WT, untrans-
fected) PC12 cells or in two PC12 cell clones stably expressing
pBoNT/C1 (BT2 and BT7). After loading with [
3H]adenine, PC12 cells
were incubated in RO 20–1724 (100 μM) for 105 min. During the last
15 min of this incubation period, 1 μM CGS 21680 was present either
alone or together with 10 μM ADP (a), 1 U/ml apyrase (b), 100 μM
MeSAMP (c) or 100 mM KCl (d). The amount of radioactivity
retrieved within the fraction of cyclic AMP (cAMP) was calculated as
percentage of the total radioactivity extracted from the cell cultures. In
order to compare the results of different cell cultures, values obtained
in the presence of ADP, apyrase, 2MesAMP or KCl were expressed as
percentage of the values obtained in the very same preparation, but in
the absence of these agents (% of control). a Results obtained in the
presence of 10 μM ADP are expressed as percentage of the results
obtained in its absence (% of control; n=6 to 10). b Results obtained in
the presence of 1 U/ml apyrase are expressed as percentage of the
results obtained in its absence (% of control; n=9 to 10). c Results
obtained in the presence of 100 μM MeSAMP are expressed as
percentage of the results obtained in its absence (n=6 to 9). d Results
obtained in the presence of 100 mM KCl are expressed as percentage
of the results obtained in its absence (n=9; ***p<0.001 versus the
results obtained in wild-type cells; #, ###p<0.05 and p<0.001 versus
the results obtained in the absence of KCl)
372 Purinergic Signalling (2007) 3:367–375tides are also sufficient to partially activate these receptors,
and depolarization of the cells fully activates the receptors
through enhanced nucleotide release to maximally suppress
cAMP synthesis [24]. In accordance with these previous
data, exposure of wild-type PC12 cells to 10 μM ADP
significantly reduced the amount of cAMP generated due to
the activation of A2A adenosine receptor by 1 μM CGS
21680 present for 15 min. In the two pBoNT/C1 expressing
clones, the inhibition of cAMP accumulation was as
pronounced as in the wild-type cells (Fig. 3a). Thus, the
adenylyl cyclase inhibiting P2Y receptors were operating
equally well in transfected as well as untransfected PC12
cells.
In the presence of apyrase (1 U/ml) to degrade
extracellular nucleotides, the cAMP accumulation triggered
by CGS 21680 was almost doubled. Again, this effect was
not different between wild-type and pBoNT/C1 expressing
cells (Fig. 3b). In accordance with these latter results, the
blockade of the receptors by the P2Y12 receptor antagonist
2-MeSAMP (100 μM; [14]) also enhanced the stimulation
of cAMP about twofold and there were no significant
differences between the three types of PC12 cultures
(Fig. 3b). Thus, the activation of the P2Y receptors
negatively linked to adenylyl cyclase by spontaneously
released nucleotides was the same whether pBoNT/C1 was
expressed or not.
When wild-type PC12 cells were depolarized by
100 mM K
+, the CGS 21680-induced cAMP accumulation
was reduced to about the same extent as by 10 μM ADP.
However, in one (BT2) of the two pBoNT/C1 expressing
clones, the depolarization of PC12 cells failed to cause any
alteration in the CGS 21680-induced cAMP accumulation;
and in the other clone (BT7), this inhibition was signifi-
cantly weaker when compared with the values obtained in
wild-type PC12 cells (Fig. 3d). Thus, depolarization-dependent
inhibition of the cAMP synthesis via P2Y12 receptors was
greatly impaired in the pBoNT/C1 expressing cells.
Discussion
In non-neural cells, release of nucleotides is mostly non-
vesicular and involves, for instance, ATP binding cassette
transporters, stretch-activated cation channels or connexin
hemichannels [22]. In neurons, however, nucleotide release
is generally believed to rely on vesicle exocytosis [27].
Here, we employed the autocrine/paracrine activation of
P2Y12 receptors in PC12 cells to investigate whether
nucleotide release from neuroendocrine cells might involve
a non-vesicular component.
Vesicle exocytosis involves the SNARE proteins syntaxin,
SNAP-25 and synaptobrevin, and cleavage of one or more
of these proteins by clostridial neurotoxins reduces or even
abolishes exocytotic transmitter release [5]. The primary
target of BoNT/C1 is syntaxin, and its inhibitory effect on
transmitter release has been correlated with the cleavage of
this protein [3]. However, in cultures of bovine chromaffin
cells [11], spinal cord [37] or hippocampal neurons [7],
BoNT/C1 was reported to cleave not only syntaxin, but also
SNAP-25. In contrast, in sensory neurons the toxin was
reported to act exclusively on syntaxin [31]. Furthermore,
in cell-free assays BoNT/C1 was found to leave either
native SNAP-25 after subcellular fractionation or recombi-
nant SNAP-25 unaltered [11, 37]. Thus, the effects of
BoNT/C1 on SNARE proteins appear to vary between
different preparations. In this study, expression of the
BoNT/C1 light chain reduced syntaxin, but not SNAP-25
immunoreactivity detected in PC12 cells. Likewise, in the
insulin secreting β-cell line HIT-T15 expression of the
BoNT/C1 light chain only affected syntaxin, even though
application of recombinant toxin to permeabilized cells did
lead to a reduction in SNAP-25 [20]. Hence, heterologous
expression of the toxin’s light chain in neuroendocrine cells
does not entirely reproduce the effects of toxin application
to these cells. Syntaxin was reported to be more sensitive to
BoNT/C1 light chain than SNAP-25 [20] and a 1000-fold
higher light chain concentration of BoNT/C was required
for SNAP-25 cleavage when compared with the other
SNAP-25-targeting serotypes BoNT/A or BoNT/E [34].
Thus, the resistance of SNAP-25 to heterologously
expressed BoNT/C1 light chain is likely due to the
relatively low toxin affinity and insufficient expression
levels of the peptide.
Nevertheless, in functional experiments, expression of
the BoNT/C1 light chain significantly reduced spontaneous
as well as depolarization-evoked release of [
3H]noradrena-
line. On the one hand, this confirms that the cleavage of
syntaxin alone is sufficient to reduce transmitter release [3].
On the other hand, this result corroborates that catechol-
amines are released from PC12 cells through vesicular
mechanisms and these are largely impaired by the expres-
sion of the BoNT/C1 light chain [10].
Considering that the heterologous expression of the
BoNT/C1 light chain did efficiently reduce vesicle exocy-
tosis, the question arises as to how this manipulation altered
the release of endogenous nucleotides. In PC12 cells,
endogenously released nucleotides activate P2Y12 recep-
tors, which mediate a decrease in the synthesis of cAMP
triggered by the activation of A2A adenosine receptors [24].
In accordance with these previous results, exposure of non-
transfected PC12 cells to the P2Y12 receptor antagonist 2-
MesAMP enhanced the cAMP synthesis. An equivalent
effect was achieved when the cells were incubated in the
nucleotide degrading enzyme apyrase, thus indicating that
spontaneously released nucleotides continuously activated
the P2Y12 receptors.
Purinergic Signalling (2007) 3:367–375 373To be able to evaluate whether the generation of PC12
clones stably expressing the BoNT/C1 light chain might
interfere with the above autocrine/paracrine signalling loop
only by affecting exocytosis, we had to establish that the
function of the P2Y12 receptor was not compromised by the
toxin’s light chain or by the clonal selection procedure.
Accordingly, 10 μM ADP, a saturating concentration of the
nucleotide in the inhibition of cAMP synthesis in PC12
cells [33], were applied to non-transfected cells and to the
two chosen cell clones (BT2 and BT7): the inhibition of
cAMP accumulation was not different in the three cultures.
Thus, the control of cAMP synthesis via the P2Y12 receptor
was not altered by pBoNT/C1 expression or by clonal
selection. Previously, we had found that the control of
voltage-gated Ca
2+ channels via this receptor subtype was
the same in a number of PC12 cell clones expressing
various types of membrane receptors [19].
Knowing that the P2Y12 receptors operated indepen-
dently of the BoNT/C1 light chain, the autocrine/paracrine
activation of the receptors was assessed. In the toxin
expressing clones, the degradation of extracellular nucleo-
tides by apyrase and the blockade of P2Y12 receptors by 2-
MesAMP had identical effects on cAMP accumulation as in
non-transfected cells. This demonstrates that the spontane-
ous release of nucleotides was not significantly affected by
the BoNT/C1 light chain.
Enhancement of nucleotide release by depolarization of
PC12 cells fully activates P2Y12 receptors and thereby
reduces cAMP synthesis to about the same extent as 10 μM
ADP. This phenomenon is based on Ca
2+-dependent vesicle
exocytosis as it is suppressed when Ca
2+ influx is prevented
by the blockade of voltage-gated Ca
2+ channels or when
extracellular nucleotides are degraded by apyrase [24]. In
support of this conclusion, the inhibition of cAMP
synthesis through a depolarization of PC12 cells by
100 mM K
+ was either significantly attenuated or entirely
abolished in the pBoNT/C1 expressing clones. Hence, the
K
+-evoked and thus Ca
2+-dependent release of nucleotides
was largely reduced by the BoNT/C1 light chain.
Taken together, the present results show that the
expression of the BoNT/C1 light chain impairs vesicular
transmitter release from PC12 cells, but does not alter the
autocrine/paracrine activation of P2Y receptors by sponta-
neously released nucleotides. Thus, the spontaneous nucle-
otide release from neuroendocrine cells may occur
independently of vesicle exocytosis. The depolarization-
evoked nucleotide release, in contrast, relies predominantly
on exocytotic mechanisms.
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